Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Stifel - The Untold Story

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

IDEXX Laboratories (NASDAQ:IDXX) President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company’s innovation pipeline, expanding commercial reach and growing use of software and artificial intelligence across veterinary diagnostics. Erickson, who recently b

MarketBeat

Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026

Henry Schein (NASDAQ:HSIC) executives said the company is on track with its 2026 commitments and value-creation plan, while pointing to continued momentum in the U.S. dental market despite broader concerns about consumer confidence. Speaking at a Stifel dental track event moderated by Stifel Managi

MarketBeat

Align Technology Highlights New Invisalign Solutions, Financing and Global Growth

Align Technology (NASDAQ:ALGN) executives highlighted product innovation, financing initiatives and international expansion as key growth drivers during a discussion at the 2026 Stifel Jaws & Paws Conference. Chief Financial Officer John Morici, joined by Shirley Stacy, vice president of financ

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Wall Street's 6 Top World Cup Stock Picks

The World Cup could give the global economy a $40 billion jolt. These are some of the stocks analysts think could benefit.

Kiplinger

MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates

MacroGenics (NASDAQ:MGNX) Chief Executive Officer Eric Risser said the biotechnology company has strengthened its balance sheet through two recent transactions while preparing for a series of clinical updates across its oncology pipeline. Speaking during an informal discussion hosted by Stifel seni

MarketBeat

Lyell Immunopharma Targets 2027 FDA Filing as CAR-T Pipeline Advances

Lyell Immunopharma (NASDAQ:LYEL) President and CEO Lynn Seely outlined the company’s clinical development priorities, regulatory strategy and manufacturing plans during a Stifel investor session moderated by Stephen Willey, senior biotech analyst at Stifel. Seely described Lyell as a cell therapy c

MarketBeat

The Trump-Intel Deal Stole Headlines, But the President Also Bought Nvidia Stock in Q1

President Trump bought up to $5 million shares in Nvidia, but a Chinese reopening seems like a faraway thought now.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Why You Should Buy Marvell Technology Stock Before May 27

Despite triple-digit gains in 2026, Marvell continues to post strong revenue growth fueled by booming data center demand.

Barchart

IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing

IDEAYA Biosciences (NASDAQ:IDYA) Chief Executive Yujiro Hata said the precision oncology company is preparing for a busy 2026, led by regulatory and clinical milestones for darovasertib in metastatic uveal melanoma and multiple data readouts across its pipeline. Speaking at a Stifel-hosted event, H

MarketBeat

Stifel Just Raised Its Price Target on Palo Alto Networks. Here's Why.

Palo Alto Networks stock rallies on a bullish note from Stifel analysts. Here’s why the investment firm sees PANW shares pushing higher in 2026.

Barchart

Adagene Spotlights ADG126 Strategy as Masked CTLA-4 Trial Advances in Colorectal Cancer

Adagene (NASDAQ:ADAG) Chief Strategy Officer Mickael Chane-Du outlined the company’s clinical strategy for its lead antibody program, ADG126, during a discussion with Stifel senior biotech analyst Stephen Willey, emphasizing the company’s focus on improving the therapeutic index of CTLA-4 inhibition

MarketBeat

Why This Analyst Thinks Texas Instruments Stock Is on the Path to $1 Trillion

While most are chasing flashy AI chipmakers, Stifel believes Texas Instruments could become the world’s first $1 trillion analog semiconductor stock.

Barchart

This Analyst Just Raised the Price Target on Coherent Stock by 50%. What to Know.

Coherent stock rallies as Stifel issues a bullish note. Here’s why analyst Ruben Roy sees COHR shares ripping higher from current levels as the year unfolds.

Barchart

Goldman: AI will save the economy someday. First, it has to stop inflating it

The AI productivity boom hasn't quite arrived yet, but the inflation from building it has. Maybe Gen Z is onto something with their AI rebellion.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

With a 76% Post-Earnings Rally, MaxLinear May Have Just Become the Top AI Infrastructure Stock to Buy

Maxlinear is well-positioned to continue benefiting from the ongoing growth of hyperscalers' data centers.

Barchart

AMD Stock Just Hit New All-Time Highs. Should You Buy Shares Here?

Despite its recent rally, AMD's valuation remains favorable.

Barchart

Why Stifel Analysts Are Watching Intel Stock Closely Before April 23

Stifel analysts raised Intel’s stock price target ahead of its Q1 earnings.

Barchart

Why Stifel Just Raised Its AMD Stock Price Target by 14%

Stifel’s 14% price target hike on AMD signals rising Wall Street conviction that the chipmaker is poised to capitalize on accelerating AI-driven demand.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Nuclear Startup Fermi Just Lost Its CEO and COO in a Shocking Move. Should You Buy the Dip in FRMI Stock Today or Stay Far, Far Away?

Fermi stock crashes as both CEO and CFO announce departure. But Stifel analysts recommend buying FRMI shares on the pullback.

The Independent UK

UK saved billions using North Sea offshore gas reserves, analysis shows

IN FULL

The Independent UK

Using North Sea gas saved Britain billions last year, analysis shows amid calls for more drilling

Last week the government denied that Ed Miliband is expected to give the green light to the first major North Sea field project in almost 10 years

MarketBeat

Stifel Financial: A Wealth Manager’s Stock for Wealth Investors

Stifel Financial offers a blend of wealth management growth and cyclical upside from deal activity, leading to a compelling long-term financial sector play.

The Guardian - UK

A gas shock – not an oil shock – from the Iran war looks more threatening

Europe and Asia will take an economic hit if the supply of Qatari LNG is halted by the closure of the strait of Hormuz

Barchart

Cava Stock Jumps Into Overbought Territory. Is It Too Late to Buy CAVA Now?

CAVA stock soared on strong Q4 earnings that triggered a technical breakout. Here’s why Stifel sees CAVA shares pushing even higher through the remainder of 2026.

Barchart

This Analyst Has Finally Had Enough of AI CapEx at Microsoft. Should You Be Done with MSFT Stock Too?

Microsoft stock is under pressure after a rare analyst downgrade raises uncomfortable questions about whether massive AI spending is finally outpacing near-term returns.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.